Acetylation of p53 at K120, K164, K320, K370, K372, K373, K381, K382, and K386 sites not only regulates its protein stability, but also influences its DNA-binding ability, while inhibition of p53 acetylation reduces the doxorubicin toxicity in cancer cells24,25. The gene discussed is TP53; the disease is cancer.